TeraRecon previews treatment planning software
Japanese postprocessing firm TeraRecon demonstrated work-in-progress treatment planning software at the ASTRO meeting Nov. 4 to 8. The software, which runs on TeraRecon’s Aquarius workstation, supports treatment planning, dose calculation, and dose
Japanese postprocessing firm TeraRecon demonstrated work-in-progress treatment planning software at the ASTRO meeting Nov. 4 to 8. The software, which runs on TeraRecon’s Aquarius workstation, supports treatment planning, dose calculation, and dose optimization. It features real-time 3-D volume rendering, using the company’s VolumePro technology, as well as such advanced features as interactive image fusion, auto contouring, beam and block entry, dose calculation, and segmented image reconstruction with isodose display. The system can also digitally reconstruct radiographs and generate dose-volume histograms for 3-D structures. An intravascular brachytherapy module provides extended radial and anisotropic dose functions.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
